Saturday 17 October 2026 Export IBRX’s income statement to Excel — free account

ImmunityBio, Inc.

ImmunityBio, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $113.3 million, up 668.3% from fiscal 2024. In the quarter to June 2026, revenue grew 93.9%, EPS fell 120.0%, free cash flow grew 13.4% and total debt rose 57.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

9.18 0.82 −8.20%

Follow IBRX

Alert me

Market cap: $10.6B
P/E: 0.0×
Fwd P/E: −8.1×
Dividend yield: —
F-score: 4/9
Altman Z: −10.16
Beneish M: 4.57
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	4	3	3
ROE Full definition →		55.01%	71.15%	117.09%	122.85%
ROA Full definition →		(78.91%)	(79.43%)	(179.83%)	(192.58%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(86.73%)	(95.65%)	(171.67%)	(208.27%)
Average Days of Receivables Full definition →		141.55	137.16	112.03	117.72
Free Cash Flow per Share Full definition →		(0.34)	(0.34)	(0.29)	(0.27)
Free Cash Flow Full definition →		(324.76)	(308.78)	(298.89)	(288.07)
Capital Expenditures Full definition →		(5.05)	(3.85)	(4.50)	(6.94)
Other line items
Cash ROIC Full definition →		(138.07%)	(140.14%)	(157.20%)	(335.13%)
Accounts Receivable Turnover Full definition →		4.56	5.04	4.68	4.39
Accounts Payable Turnover Full definition →		0.63	0.11	0.08	0.11
Inventory Turnover Full definition →		1.14	0.16	0.21	0.26
Average Days of Payables Full definition →		425.17	3,382.43	4,378.44	3,999.67
Days of Inventory on Hand Full definition →		493.66	441.10	213.99	646.67
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		230.06%	192.92%	169.04%	147.11%
Selling, General and Administrative Expense of Revenue Full definition →		185.34%	132.41%	115.71%	104.11%
Share Based Compensation of Revenue Full definition →		44.94%	32.49%	25.14%	20.70%
Interest Coverage Full definition →		(2.14)	(2.28)	(2.36)	(2.23)
Operating CF/Net income Full definition →		0.92	0.87	0.34	0.28
Depreciation/Fixed assets Full definition →		0.16	0.14	0.13	0.15
Capex/Depreciation Full definition →		(0.24)	(0.25)	(0.31)	(0.42)
Revenue per Share Full definition →		0.09	0.12	0.14	0.16
Operating CF per Share Full definition →		(0.34)	(0.33)	(0.29)	(0.27)
Capex per Share Full definition →		(0.01)	0.00	0.00	(0.01)
Capex to Sales Full definition →		0.06	0.03	0.03	0.04

Show all line items

Columns are period end dates

Stockrow Weekly